POLYMED BIOPHARMACEUTICALS

polymed-biopharmaceuticals-logo

Polymed Biopharmaceuticals use artificial intelligence and structural chemistry to aid drug design. They conduct drug research and development projects for cancer, autoimmune diseases, and anti aging. Polymed Biopharmaceuticals develops small molecule inhibitors and antibody based drugs.

#SimilarOrganizations #Financial #Website #More

POLYMED BIOPHARMACEUTICALS

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2018-01-22

Address:
Hangzhou, Zhejiang, China

Country:
China

Website Url:
http://www.polymedbiopharma.com

Total Employee:
11+

Status:
Active

Contact:
+1-7815720583

Email Addresses:
[email protected]

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF SSL By Default Font Awesome ASP.NET IIS Japanese Yen IIS 10


Similar Organizations

alchemedicine-logo

Alchemedicine

Alchemedicine is a drug research and development company.

amitech-therapeutic-solutions-logo

Amitech Therapeutic Solutions

Amitech Therapeutic Solutions specializes in oncology drug research and development.

crystal-genomics-logo

Crystal Genomics

Crystal Genomics is a drug research and development company.

primoris-therapeutics-logo

Primoris Therapeutics

Primoris Therapeutics is a medical research and development center.

ubix-therapeutics-logo

Ubix Therapeutics

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

usun-bio-logo

USUN BIO

USUN BIO is a drug research and development company.

xforest-therapeutics-logo

xFOREST Therapeutics

xFOREST Therapeutics develops a drug discovery platform that targets RNA structures.

Investors List

zjkf-capital-management_image

ZJKF Capital Management

ZJKF Capital Management investment in Series A - Polymed Biopharmaceuticals

Official Site Inspections

http://www.polymedbiopharma.com

  • Host name: 47.88.101.124
  • IP address: 47.88.101.124
  • Location: San Mateo United States
  • Latitude: 37.5517
  • Longitude: -122.33
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94402

Loading ...

More informations about "Polymed Biopharmaceuticals"

Polymed Biopharmaceuticals

In 2011 Dr. Lu joined Novartis to lead its biologics discovery unit in Shanghai where he worked for 5 years. As part of the global NIBR organization, the unit worked with disease areas such as …See details»

杭州多域生物技术有限公司

生物技术、医药 . 中国科学技术大学化学学士,美国普渡大学有机化学博士,具有20年新药研发经验,曾任职于国际大药厂美国辉瑞等公司并担任项目总负责人,带领课题组将6个药物推进到临 …See details»

Polymed Biopharmaceuticals - Crunchbase Company Profile

Contact Email [email protected] Phone Number +1-7815720583 Polymed Biopharmaceuticals use artificial intelligence and structural chemistry to aid drug design.See details»

Polymed Biopharmaceuticals Company Profile | Management and …

[email protected]: Polymed Biopharmaceuticals Top Competitors. Company Employees Revenue Top technologies; Orphagen Pharmaceuticals Inc. 7: $1.3 M: Provid …See details»

Polymed Biopharmaceuticals

Dec 12, 2022 Shaanxi Junying Jiacheng Fund is a professional fund management organization. The fund adopts a two-tier investment and operation model of "Parental Fund + Sister Fund …See details»

Polymed Biopharmaceuticals - Overview, News & Similar

Polymed Biopharmaceuticals contact info: Phone number: (781) 572-0583 Website: www.polymedbiopharma.com What does Polymed Biopharmaceuticals do? About Polymed: …See details»

Polymed Biopharmaceuticals - LinkedIn

Learn more about HPB-092 at www.polymedbiopharma.com. …see more 1 Like Comment Share Polymed Biopharmaceuticals 57 followers 4mo Report this post Polymed Biopharmaceuticals …See details»

Polymed Biopharmaceuticals - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»

Polymed Biopharmaceuticals - Company Profile - Tracxn

Nov 27, 2024 Polymed Biopharmaceuticals - Developer of small molecule therapeutics for cancer and autoimmune diseases. Raised a total funding of $7.73M over 1 round from 2 …See details»

Polymed Biopharmaceuticals - PitchBook

Polymed Biopharmaceuticals General Information Description. Operator of a biopharmaceutical company intended to focus on novel therapies in the areas of oncology and auto-immune …See details»

Polymed Biopharmaceuticals - Products, Competitors, Financials ...

Polymedbiopharma.com. Overview & Products; Financials; Founded Year 2018. Stage Seed VC - II | Alive. Total Raised $7.74M. Mosaic Score. The Mosaic Score is an algorithm that …See details»

Polymed Biopharmaceuticals

Dr. Jason S. Xiang: Founder and Chief Executive Officer. Dr. Xiang is an accomplished Medicinal Chemist with over 20 years’ experience in discovery and development of therapeutics for …See details»

Polymed Biopharmaceuticals Asset Profile | Preqin

Www.polymedbiopharma.com Verticals HealthTech Company Stage Angel & Seed Total Amount Raised Subscriber access only Time to go Pro Get Preqin Pro for unrestricted access to …See details»

多域生物 | 项目信息-36氪

多域生物是一家以中国杭州为基地,面向国际的创新型新药研发公司。公司致力于开发全球首创(first-in-class)和同类最优(best-in-class)的新药研发项目,尤其专注于癌症,自身免疫疾 …See details»

Polymed Biopharmaceuticals - VentureRadar

Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»

Polymed Biopharmaceuticals

Nov 28, 2022 contact Room 401, Building 3, 110 Liuze Street, Yuhang District, Hangzhou, Zhejiang Province 311100, China (+01) 7815720583(US)See details»

Polymed Biopharmaceuticals’ Post - LinkedIn

Learn more about Polymed's lead asset, the potent and selective protein degrader HPB-143, at www.polymedbiopharma.comSee details»

周禾博士加入多域生物,担任首席运营官(COO)医药新闻-ByDru…

⌈ByDrug医药新闻摘要⌋ 2023-11-08 17:12,多域生物 Polymed Biopharma:2023年11月8日,中国杭州,杭州多域生物技术有限公司(Polymed Biopharmaceuticals,下称“多域生物”)近日宣 …See details»

Polymed Biopharmaceuticals

May 15, 2021 Jason Xiang, [email protected] For Arbella Therapeutics: Fred Martin, [email protected]. At Polymed we focus on novel therapies in the areas of …See details»

News - Polymed Biopharmaceuticals

Jul 30, 2021 Polymed Biopharmaceuticals, Inc., recently concluded an RMB 50 million pre-A round fundraising invested solely by Matrix Partners China. The fund raised from this round …See details»

linkstock.net © 2022. All rights reserved